D-0068-2022 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0068-2022 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Oct 12, 2021 and is designated Class III. Reason for recall: Failed Moisture Limits The recall status is terminated (terminated Aug 31, 2023). Affected quantity: 22,752 blister packs.

Recall details

Product Type
Drugs
Report Date
Nov 3, 2021
Initiation Date
Oct 12, 2021
Termination Date
Aug 31, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,752 blister packs

Product description

Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15

Reason for recall

Failed Moisture Limits

Distribution pattern

Nationwide within the United States

Code information

Lot #: AC14635, Exp. Date 12/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0068-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0068-2022. Report a data issue: hello@regdatalab.com.